Get the tools used by (smart)2 investors.

Net Income to Common CAGR (10y)

Join now and get access to the full platform

Search for company or ETF

 

  0 results available. Select is focused ,type to refine list, press Down to open the menu,

1.00
Price
Fair Value
Upside
0.98 - 7.79
52-week range

Analysis

Fiscal Years
Trailing Twelve Months
Fiscal Halfs
Fiscal Quarters
Daily
Hide this widget

Benchmarks

Hide this widget

No data available

Metric Usage

Hide this widget

No data available

Similar Metrics

Hide this widget

No data available

Search for metric or datapoint

Definition of Net Income to Common CAGR (10y)

Hide this widget

No data available

Sector Benchmark Analysis

Sector
Industry Group
Industry
Hide this widget
-205,215.8%-140,215.8%-75,215.8%46,906.5%0200400600

The chart above depicts the distribution of net income to common cagr (10y) for companies operating in the Healthcare sector in the Developed economic region. Over 1,870 companies were considered in this analysis, and 1,797 had meaningful values. The average net income to common cagr (10y) of companies in the sector is -5,376.8% with a standard deviation of 22,461.0%.

Inozyme Pharma Inc's Net Income to Common CAGR (10y) of -1,858.4% ranks in the 26.6% percentile for the sector. The following table provides additional summary stats:

Net Income to Common CAGR (10y) In The Healthcare Sector
Economic Risk RegionDeveloped
Total Constituents1,871
Included Constituents1,797
Min-209,208.5%
Max42,263.8%
Median-178.1%
Mean-5,376.8%
Standard Deviation22,461.0%

You can find companies with similar net income to common cagr (10y) using this stock screener.

All rights reserved. Terms Of Use